ZVL-10281-36106
4 vaccinations
5 coded responses
35 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 921 / CA
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-03
- 2021-03-04
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-16
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-21
Health check-in — day 0, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Bone pain, Neuralgia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Sharp nerve pain, aching bonesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-06-20
-
2021-09-19
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-09-19
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-20
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-09
Dose 3 — Pfizer-BioNTech
-
2022-09-16
Dose 4 — Moderna
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-10-07
- 2022-10-16
- 2022-10-21
-
2022-10-28
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: GoodFree text: ColdMedDRA releases: 2024-11 · check-in free text available
-
2022-12-18
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: Minor cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2023-03-19
Survey response — 6 months, dose 4MedDRA: Cough, Gastroenteritis, Nasal congestion, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-19 | Successful 2021-09-20 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Sharp nerve pain, aching bones
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 12 — day 42, dose 4
Symptoms: Cold
Release 12 — 3 months, dose 4
Symptoms: Minor cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Gastroenteritis | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Bone pain | ✓ | ✓ | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release